Ignite Creation Date:
2024-05-06 @ 9:49 AM
Last Modification Date:
2024-10-26 @ 12:20 PM
Study NCT ID:
NCT03087448
Status:
TERMINATED
Last Update Posted:
2022-12-27
First Post:
2017-02-10
Brief Title:
Ceritinib Trametinib in Patients With Advanced ALK-Positive Non-Small Cell Lung Cancer NSCLC
Sponsor:
University of California San Francisco
Organization:
University of California San Francisco
Organization Data
Organization:
University of California San Francisco
Class:
OTHER
Study ID:
166512
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
University of California San Francisco
Lead Sponsor Class:
OTHER
Responsible Party:
None
Responsible Party Title:
None
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
None
Old Name:
None
Old Organization:
None
Collaborators
| Name | Class |
|---|---|
| University of California Davis | OTHER |
| Novartis Pharmaceuticals | INDUSTRY |